Background The metabolic syndrome (MS) is a leading cause of death worldwide. Several
studies have found MS to be prevalent in various African regions. However, no specific …

Background A high prevalence of metabolic syndrome and its components in patients with
psychotic disorders may increase the risk for cardiovascular diseases. Unfortunately …

Introduction Mental and substance use disorders are leading causes of disability worldwide.
Yet only 10% of individuals globally receive treatment for such disorders, with an even …

Objective: To optimize the early diagnosis of glucose metabolism impairments in patients
with psychiatric disorders treated with antipsychotic medications. Methodology: This is a …

Abstract Background Metabolic syndrome (MetS) is common in major depressive disorder
(MDD), but its relationship with thyroid hormones remains unclear. We aimed to examine the …

Introduction The metabolic syndrome, a cluster of inter-related risk factors for cardiovascular
diseases is highly prevalent among individuals with obesity and sedentary lifestyle. Chronic …

Cardiovascular disease (CVD) is a leading cause of morbidity and mortality worldwide.
Patients with severe mental illness (SMI) are at a higher risk for developing CVD and have a …

Background Metabolic syndrome is a major public health challenge in both developed and
developing countries. The burden of this disease is high, even in patients with psychiatric …

Objective In 2015, Mbarara University of Science and Technology was awarded the Mbarara
University Research Training Initiative (MURTI) under grant number D43 TW010128 to build …

Background: Metabolic syndrome, identified as a global health crisis by WHO, affects 20-
25% of the population, doubling the risk of death and tripling heart attack risk. Its prevalence …